Prats
Aníbal Villatoro Prats, Peterborough GB
Patent application number | Description | Published |
---|---|---|
20120247085 | Compression Ignition Engine System With Diesel Particulate Filter Coated With NOx Reduction Catalyst And Stable Method Of Operation - An engine system includes an electronically controlled compression ignition engine configured to burn diesel fuel to produce an exhaust with a temperature and NOx to soot ratio. An aftertreatment system is fluidly connected to the engine and includes a diesel oxidation catalyst, a reductant supply, and a diesel particulate filter coated with a NOx reduction catalyst but not the diesel oxidation catalyst. A soot load density in the diesel particulate filter is stabilized by oxidizing soot at about a same rate as the compression ignition engine is supplying soot to the aftertreatment system without active regeneration. A NOx reduction reaction is catalyzed by the NOx reduction catalyst on the diesel particulate filter. | 10-04-2012 |
Antonio E. Prats, Shrewsbury MA
Patent application number | Description | Published |
---|---|---|
20150283362 | URETERAL STENT WITH ANTI-MIGRATION FEATURES - Ureteral stents include a tubular body defining a lumen and have (i) a distal kidney section to be placed in or near a patient's kidney, (ii) a proximal bladder section to be placed within or near the patient's bladder, and (iii) a ureter section between the distal and proximal sections to be placed within the patient's ureter. A first anti-migration feature may be provided at the proximal bladder section and may include one or more projections extending outward from the tubular body. The first anti-migration feature may extend less than a total length of the proximal bladder section, and may be configured to not enter the patient's bladder. Furthermore, a second anti-migration feature may be provided at the distal kidney section, the proximal bladder section, or both. | 10-08-2015 |
Elena Prats, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20130203876 | METHOD TO START-UP A PROCESS TO MAKE EXPANDABLE VINYL AROMATIC POLYMERS - The present invention is a method to start-up a process to make expandable vinyl aromatic polymer pellets comprising, | 08-08-2013 |
20140319715 | Method to Start-up a Process to Make Non-Expandable Vinyl Aromatic Polymers - A method for producing non-expandable pellets can include introducing a vinyl aromatic polymer to a pelletizer (L). The pelletizer (L) can have a die plate having a holes of large diameter. During the start-up of the production of the non-expandable pellets, pellets can be produced in the pelletizer (L). When the polymer flow rate is in the operating range of the pelletizer (S), the introduction of the vinyl aromatic polymer can be switched from the pelletizer (L) to the pelletizer (S). The pelletizer (S) can be operated at conditions effective to produce the non-expandable pellets. The pelletizer (S) can have a die plate having holes of small diameter. The non-expandable pellets can be recovered from the pelletizer (S), and the pellets can be recovered from the pelletizer (L). | 10-30-2014 |
Herve Prats, Toulouse Cedex 4 FR
Patent application number | Description | Published |
---|---|---|
20110250210 | Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1) - The present invention relates to neutralizing antibodies and fragments thereof directed against Platelet Factor-4 variant 1 (PF4v1) and their use for treating pathologies that require induction of angiogenesis or diseases associated with pathological angiogenesis. | 10-13-2011 |
Hervé Prats, Toulouse Cedex FR
Patent application number | Description | Published |
---|---|---|
20090305343 | Method For Expressing Polypeptides In Eukaryotic Cells Using Alternative Splicing - This invention relates to an expression cassette for expressing polypeptides in eukaryotic cells using alternative splicing. The expression cassette comprises in 5′ to 3′ downstream direction: a promoter; a sequence transcribed in a 5′ untranslated region (5′UTR); a donor splice site; an intron; a first acceptor splice site; a first cistron encoding a first polypeptide; a second acceptor splice site; a second cistron encoding a second polypeptide; an internal ribosome entry site (IRES) operably linked to a selection marker; and a sequence transcribed in a 3″ untranslated region (3′UTR) including a polyadenylation signal, wherein the polyadenylation signal is unique. | 12-10-2009 |